Caulder, E., Palavecino, E., Beardsley, J., Johnson, J., Luther, V., Ohl, C., & Williamson, J. (2019). 2249. Impact of Minimum Inhibitory Concentration on Clinical Outcomes of Daptomycin for VRE Bloodstream Infection Among Neutropenic Oncology Patients. Open Forum Infect Dis.
Chicago Style CitationCaulder, Elisabeth, Elizabeth Palavecino, James Beardsley, James Johnson, Vera Luther, Christopher Ohl, i John Williamson. "2249. Impact of Minimum Inhibitory Concentration On Clinical Outcomes of Daptomycin for VRE Bloodstream Infection Among Neutropenic Oncology Patients." Open Forum Infect Dis 2019.
Cita MLACaulder, Elisabeth, et al. "2249. Impact of Minimum Inhibitory Concentration On Clinical Outcomes of Daptomycin for VRE Bloodstream Infection Among Neutropenic Oncology Patients." Open Forum Infect Dis 2019.